4//SEC Filing
BEN-MAIMON CAROLE 4
Accession 0000899243-23-003734
CIK 0001374690other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:15 PM ET
Size
7.5 KB
Accession
0000899243-23-003734
Insider Transaction Report
Form 4
BEN-MAIMON CAROLE
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-01-31+205,000→ 261,829 total - Award
Stock Option (Right to Buy)
2023-01-31+325,000→ 325,000 totalExercise: $4.94Exp: 2033-01-31→ Common Stock (325,000 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The option vests 25% on January 31, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
Documents
Issuer
Larimar Therapeutics, Inc.
CIK 0001374690
Entity typeother
Related Parties
1- filerCIK 0001529611
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:15 PM ET
- Size
- 7.5 KB